Granahan Investment Management XERIS PHARMACEUTICALS IN ownership

XERIS PHARMACEUTICALS IN's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Granahan Investment Management ownership history of XERIS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$1,139
-37.9%
465,049
+3.2%
0.02%
-35.3%
Q2 2021$1,833
-6.3%
450,414
+3.9%
0.03%
-17.1%
Q1 2021$1,956
+27.2%
433,710
+38.7%
0.04%
+17.1%
Q4 2020$1,538
-25.1%
312,590
-9.8%
0.04%
-50.0%
Q3 2020$2,054
+127.0%
346,428
+1.8%
0.07%
+112.1%
Q2 2020$905
-35.5%
340,403
+312.6%
0.03%
-66.7%
Q4 2018$1,403
-39.2%
82,504
-37.1%
0.10%
-20.8%
Q3 2018$2,306
-7.1%
131,145
+0.3%
0.12%
-16.1%
Q2 2018$2,481130,7000.15%